Understanding naloxone access through Medicaid
July 23, 2021 | addiction
Center for HOPES Research Scholar Lisa Frazier is co-author of a letter to the editor in the new issue of Drug and Alcohol Dependence. In “Letter to the Editor Regarding: Medicaid Prescription Limits and Their Implications for Naloxone Accessibility (by Roberts et al., 2021),” Dr. Frazier and her colleagues from Kentucky, Massachusetts, and New York explain how several nuances of state Medicaid policies affect the conclusions of an article published earlier in the year. Roberts, et al. identify and describe policies that limit the number of prescriptions a beneficiary may fill across state Medicaid programs. However, their conclusion about monthly prescription fill limit policies overstates the proportion of the adult Medicaid population for whom access to naloxone is potentially restricted.
Read more and access the article.